Author

S. Pavlova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

S. Pospisilova· 2 shared A. Smirnova· 1 shared A. Volakhava· 1 shared D. Wahl· 1 shared H. Peschelova· 1 shared H. Synackova· 1 shared I. Mamedov· 1 shared I. Staniczkova Zambo· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. Pospisilova

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits

L. Curylova, I. Staniczkova Zambo, J. Neradil, M. Kyr, N. Jurackova, S. Pavlova, K. Polaskova, P. Mudry, J. Sterba, R. Veselska, J. Skoda

This study shows that restoring p53 activity can target aggressive pediatric sarcomas with stem-like traits by inducing apoptosis in cancer cells while sparing healthy cells.

bioRxiv · Jan 17, 2024Cancer Biology

Mobile retroelements induced by hypomethylating agents are restricted to transpose in myeloid malignancies

S. Pavlova, M. Krzyzankova, A. Volakhava, A. Smirnova, T. Grigoreva, Z. Jaskova, H. Synackova, D. Wahl, M. Bohunova, L. Cervinek, S. Pospisilova, I. Mamedov, K. Plevova

The paper investigates whether hypomethylating agents induce retroelement activity and somatic retrotranspositions in myeloid malignancies but finds no de novo retrotransposition events.

bioRxiv · Jul 30, 2023 · PreprintCancer Biology

Lyn controls chemotaxis and motility of CLL cells via phosphorylation of ROR1.

Z. Dave, O. Vondalova-Blanarova, S. Cada, P. Janovska, N. Zezula, M. Behal, K. Hanakova, S. R. Ganjani, P. Krejci, K. Gmöryöva, H. Peschelova, M. Smida, Z. Zdrahal, S. Pavlova, J. Kotaskova, , V. Bryja

This study shows Lyn phosphorylates ROR1, affecting its surface levels and migratory properties in CLL cells, linking BCR and ROR1 signaling.

bioRxiv · May 29, 2020Cancer Biology